We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

13 hedge funds and large institutions have $2.85M invested in AIM ImmunoTech in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

7% less funds holding

Funds holding: 14 → 13 (-1)

16% less capital invested

Capital invested by funds: $3.38M → $2.85M (-$528K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$38.4K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$9.61K
2
WS
Wedbush Securities
California
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$981K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$953K – – –
OAM
3
Occidental Asset Management
California
$390K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$238K +$38.4K +4 +18%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$153K – – –
Northern Trust
6
Northern Trust
Illinois
$35K – – –
UBS Group
7
UBS Group
Switzerland
$19K – – –
VKH
8
Virtu KCG Holdings
New York
$18K -$9.61K -1 -33%
State Street
9
State Street
Massachusetts
$14K – – –
BA
10
BlackRock Advisors
Delaware
$12K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$11K – – –
GC
12
Guggenheim Capital
Illinois
$7K – – –
Goldman Sachs
13
Goldman Sachs
New York
$5K – – –
TSS
14
Two Sigma Securities
New York
$4K – – –
BTS
15
BB&T Securities
Virginia
$2K – – –
Wells Fargo
16
Wells Fargo
California
$2K – – –
DC
17
Davenport & Co
Virginia
$1.71K – – –
CHC
18
City Holding Co
West Virginia
$1K – – –
ICAS
19
Investors Capital Advisory Services
Massachusetts
$1K – – –
WS
20
Wedbush Securities
California
– -$7K -1 Closed

AIM Hedge Fund Activity: Q3 2015 in Review

13 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2015, worth a combined $2.85M — down 16% from $3.38M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AIM and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $38.4K. The largest seller was Virtu KCG Holdings, cutting an estimated $9.61K.

  • 13 institutional investors held AIM ImmunoTech (AIM) as of Q3 2015, down from 14 in Q2 2015.
  • Funds reported $2.85M of AIM ImmunoTech stock for Q3 2015, down 16% quarter-over-quarter.
  • 0 funds opened new AIM ImmunoTech positions in Q3 2015 and 1 closed out, a net change of -1 holder.
  • The largest AIM ImmunoTech buyer in Q3 2015 was Renaissance Technologies, an estimated $38.4K added.
  • The largest AIM ImmunoTech seller in Q3 2015 was Virtu KCG Holdings, an estimated $9.61K sold.

Based on aggregated 13F filings for Q3 2015.